MAI
MCID: MYC088
MIFTS: 29

Mycobacterium Avium Complex Infections (MAI)

Categories: Immune diseases, Rare diseases

Aliases & Classifications for Mycobacterium Avium Complex Infections

MalaCards integrated aliases for Mycobacterium Avium Complex Infections:

Name: Mycobacterium Avium Complex Infections 52
Mycobacterium Avium-Intracellulare Infection 52
Mycobacterium Avium-Intracellulare 52
Mycobacterium Avium 52
Mai 52

Classifications:



Summaries for Mycobacterium Avium Complex Infections

NIH Rare Diseases : 52 Mycobacterium avium complex (MAC) refers to infections caused by two types of bacteria : Mycobacterium avium and Mycobacterium intracellulare . MAC bacteria do not make most people sick. However, people with immune systems that do not work well (from HIV/AIDS or certain cancers for example) or people with lung disease (such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis) are at the greatest risk for getting sick from MAC Infections. Elderly women are also at higher risk to get sick from MAC infections. There are 3 types of MAC infections. Pulmonary MAC infections - Affect the lungs and are the most common type. These mainly affect elderly women and people who already have lung disease. Disseminated MAC infections - Have spread throughout the body. This type is usually seen in people with advanced AIDS. MAC-associated lymphadenitis - Causes swelling of the lymph nodes (especially in the neck) and is the most common in young children who have normal immune systems. While the symptoms are different for each type of infection, general symptoms include fever, night sweats, weight loss, and fatigue. MAC bacteria are found in water, soil, and dust. They infect people when the bacteria are inhaled or swallowed. MAC bacteria are not usually spread from person to person. MAC infections are diagnosed by a combination of imaging scans and identifying the bacteria in cultures of cells from the infected area. Treatment for MAC infection depends on the type and may include antibiotics , antiviral medications, or surgery.

MalaCards based summary : Mycobacterium Avium Complex Infections, also known as mycobacterium avium-intracellulare infection, is related to may-thurner syndrome and macs syndrome. The drugs Clofazimine and Fluconazole have been mentioned in the context of this disorder. Affiliated tissues include lung, lymph node and t cells.

Related Diseases for Mycobacterium Avium Complex Infections

Diseases related to Mycobacterium Avium Complex Infections via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 6673)
# Related Disease Score Top Affiliating Genes
1 may-thurner syndrome 12.6
2 macs syndrome 12.4
3 macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 12.2
4 immunodeficiency 31a 11.5
5 androgen insensitivity syndrome, mild 11.3
6 migraine with or without aura 1 11.2
7 alzheimer disease 11.1
8 stroke, ischemic 11.1
9 traumatic brain injury 11.1
10 attention deficit-hyperactivity disorder 11.1
11 tremor 11.1
12 dementia 11.1
13 myocardial infarction 11.1
14 prostate cancer 11.1
15 mccune-albright syndrome 11.1
16 herpes zoster 11.1
17 hypogonadotropic hypogonadism 11.1
18 celiac disease 1 11.1
19 neuroblastoma 11.1
20 gastrointestinal stromal tumor 11.1
21 autism spectrum disorder 11.1
22 dementia, lewy body 11.1
23 post-traumatic stress disorder 11.1
24 myeloma, multiple 11.1
25 fatty liver disease 11.1
26 diabetes mellitus, type i 11.1
27 gastric cancer 11.1
28 eating disorder 11.1
29 essential tremor 11.1
30 schizophrenia 11.1
31 chronic pain 11.1
32 endometriosis 11.1
33 atrial fibrillation 11.0
34 lymphangioleiomyomatosis 11.0
35 spinal muscular atrophy 11.0
36 cervical cancer 11.0
37 dermatitis 11.0
38 ovarian cancer 11.0
39 pre-eclampsia 11.0
40 down syndrome 11.0
41 sjogren syndrome 11.0
42 lyme disease 11.0
43 multiple sclerosis 11.0
44 microphthalmia 11.0
45 graves' disease 11.0
46 hidradenitis suppurativa 11.0
47 amyotrophic lateral sclerosis 1 11.0
48 breast cancer 11.0
49 anxiety 11.0
50 alpha-1-antitrypsin deficiency 11.0

Graphical network of the top 20 diseases related to Mycobacterium Avium Complex Infections:



Diseases related to Mycobacterium Avium Complex Infections

Symptoms & Phenotypes for Mycobacterium Avium Complex Infections

Drugs & Therapeutics for Mycobacterium Avium Complex Infections

Drugs for Mycobacterium Avium Complex Infections (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 97)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clofazimine Approved, Investigational Phase 3 2030-63-9 2794
2
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
3
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
4
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
5
Amikacin Approved, Investigational, Vet_approved Phase 3 37517-28-5 37768
6
Azithromycin Approved Phase 2, Phase 3 83905-01-5 447043 55185
7
Clarithromycin Approved Phase 3 81103-11-9 84029
8
Ethambutol Approved Phase 2, Phase 3 74-55-5 3279 14052
9
Rifampicin Approved Phase 2, Phase 3 13292-46-1 5381226 5458213
10 Anti-Inflammatory Agents Phase 3
11 Hormone Antagonists Phase 3
12 Antifungal Agents Phase 3
13 Antitubercular Agents Phase 2, Phase 3
14 Antibiotics, Antitubercular Phase 2, Phase 3
15 Cytochrome P-450 CYP3A Inhibitors Phase 3
16 Cytochrome P-450 Enzyme Inhibitors Phase 3
17
Nelfinavir Approved Phase 2 159989-64-7 64143
18
Rifapentine Approved, Investigational Phase 2 61379-65-5 6323497
19
Streptomycin Approved, Vet_approved Phase 2 57-92-1 19649
20
Indinavir Approved Phase 2 150378-17-9 5362440
21
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
22
Ciprofloxacin Approved, Investigational Phase 2 85721-33-1 2764
23
Interferon beta-1a Approved, Investigational Phase 2 145258-61-3 6438354
24
Rifabutin Approved, Investigational Phase 2 72559-06-9 6323490 46783538
25
Doxycycline Approved, Investigational, Vet_approved Phase 2 564-25-0 54671203
26
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
27
Busulfan Approved, Investigational Phase 2 55-98-1 2478
28
Tacrolimus Approved, Investigational Phase 2 104987-11-3 445643 439492 6473866
29
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
30
Mycophenolic acid Approved Phase 2 24280-93-1 446541
31
protease inhibitors Phase 2
32 HIV Protease Inhibitors Phase 2
33 Anti-HIV Agents Phase 2
34 Anti-Retroviral Agents Phase 2
35 Thioacetazone Phase 2
36 Interferon-beta Phase 2
37 Antilymphocyte Serum Phase 2
38 Anti-Bacterial Agents Phase 2
39 Anti-Infective Agents Phase 2
40 Antimetabolites Phase 2
41 Immunologic Factors Phase 2
42 Immunosuppressive Agents Phase 2
43 Antiprotozoal Agents Phase 2
44 Antiparasitic Agents Phase 2
45 Antimalarials Phase 2
46 Alkylating Agents Phase 2
47 Calcineurin Inhibitors Phase 2
48 Antirheumatic Agents Phase 2
49 Antiviral Agents Phase 2
50 interferons Phase 2

Interventional clinical trials:

(show top 50) (show all 82)
# Name Status NCT ID Phase Drugs
1 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4 Rifabutin, Clarithromycin, and Clofazimine
2 An Open-Label Randomized Pharmacokinetic/Pharmacodynamic Study of Mycobutin (Rifabutin) or Rifabutin in Combination With Myambutol (Ethambutol) for Prophylaxis of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts <= 100 Cells/mm3 Completed NCT00002343 Phase 4 Ethambutol hydrochloride;Rifabutin
3 Open Study of Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) Completed NCT00600769 Phase 4 Clarithromycin
4 Open, Noncomparative Trial of Azithromycin in the Treatment of M.Avium Complex (MAC) Lung Disease Completed NCT00599079 Phase 4 Azithromycin
5 Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease Completed NCT00598962 Phase 4 Azithromycin;Rifabutin/rifampin
6 Open, Noncomparative Trial of Multidrug Regimens Containing Clarithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease Completed NCT00598897 Phase 4 clarithromycin, rifabutin
7 A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo Completed NCT00002101 Phase 3 Ethambutol hydrochloride;Clarithromycin;Rifabutin
8 A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients Completed NCT00002140 Phase 3 Ethambutol hydrochloride;Clarithromycin;Azithromycin
9 An Open-Label, Randomized Trial of Four Treatment Regimens for Patients With Disseminated Mycobacterium Avium Complex Disease and Acquired Immunodeficiency Syndrome (AIDS) Completed NCT00001047 Phase 3 Ethambutol hydrochloride;Clarithromycin;Clofazimine;Rifabutin
10 A Prospective, Randomized, Comparative Study of the Safety and Efficacy of Clarithromycin Versus Rifabutin Versus the Combination of Clarithromycin Plus Rifabutin for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia or Disseminated MAC Disease in HIV-Infected Patients With CD4 Lymphocyte Counts <= 100 Cells/mm3 Completed NCT00001030 Phase 3 Clarithromycin;Rifabutin
11 Clinical Efficacy of Rifabutin in the Treatment of Serious and Life Threatening Infections Due to Mycobacterium Avium Complex, or Drug Resistant Mycobacterium Tuberculosis, or Other Drug Resistant Mycobacterium Completed NCT03164291 Phase 3 Rifabutin
12 A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients Completed NCT00002122 Phase 3 Azithromycin;Rifabutin;Fluconazole
13 An Open-Label Safety Extension Study to a Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients With Nontuberculous Mycobacterial (NTM) Lung Infections Caused by Mycobacterium Avium Complex (MAC) That Are Refractory to Treatment Completed NCT02628600 Phase 3 LAI 590 mg;Multi-drug regimen
14 An Open Label Study to Assess the Efficacy and Safety of Fixed-Dose Combination RHB-104 in Subjects With Active Crohn's Disease Despite 26 Weeks of Participation in the MAP US RHB-104-01 Study Completed NCT03009396 Phase 3 RHB-104; a fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine
15 A Randomized, Open-label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients With Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC) That Are Refractory to Treatment Completed NCT02344004 Phase 3 LAI (Liposomal Amikacin for Inhalation) 590 mg
16 Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Recruiting NCT03672630 Phase 2, Phase 3 Azithromycin;Ethambutol;Rifampin
17 CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections Recruiting NCT03236987 Phase 3 Clarithromycin 1000 MG;Azithromycin 250 mg;Rifampicin;Ethambutol
18 A Pilot, Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Disseminated Mycobacterium Avium Complex Disease (MAC) in AIDS Patients Who Are Receiving Standard Acute Treatment for This Opportunistic Infection Completed NCT00002170 Phase 2 Nelfinavir mesylate
19 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS Completed NCT00000644 Phase 2 Clarithromycin
20 Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. Completed NCT00002192 Phase 2 Rifapentine;Ethambutol hydrochloride;Clarithromycin;Azithromycin
21 The Effect of Therapy on the Tissue Burden of Disseminated MAC Infection as Measured by Quantitative Bone Marrow Culture and Correlation With Quantitative Blood Culture in HIV-Infected Patients Completed NCT00001039 Phase 2 Ethambutol hydrochloride;Clarithromycin
22 Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease Completed NCT00004689 Phase 2 amithiozone;clarithromycin;ethambutol;rifampin;streptomycin
23 A Phase II/III Prospective, Multicenter, Randomized, Controlled Trial Comparing the Safety and Efficacy of Three Clarithromycin-Containing Combination Drug Regimens for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Disease in Persons With AIDS Completed NCT00001058 Phase 2 Indinavir sulfate;Ritonavir;Ethambutol hydrochloride;Clarithromycin;Rifabutin
24 A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. Completed NCT00000641 Phase 2 Ciprofloxacin hydrochloride;Ethambutol hydrochloride;Amikacin sulfate;Azithromycin;Rifampin;Clofazimine
25 A Randomized, Double-Blinded, Placebo-Controlled, Phase II Study of the Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterial in Previously Treated or Moderate to Severe Pulmonary Mycobacterium Avium Complex (MAC) Infection Completed NCT00021567 Phase 2 Interferon Gamma for Aerosol
26 A Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of Fixed Dose Combination RHB-104 as Add-On Therapy to Interferon Beta-1a in Patients Treated for Relapsing Remitting Multiple Sclerosis Completed NCT01717664 Phase 2 RHB-104
27 A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease Completed NCT01315236 Phase 2 Liposomal amikacin for inhalation (LAI);placebo
28 Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for Patients With GATA2 Mutations Completed NCT00923364 Phase 2 Cyclophosphamide (CTX, Cytoxan);Fludarabine(Fludara,Berlex Laboratories);Equine Anti-Thymocyte Globulin
29 Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study Recruiting NCT04287049 Phase 2 Azithromycin
30 Phase 2 Study of Clofazimine for the Treatment of Pulmonary Mycobacterium Avium Disease Recruiting NCT02968212 Phase 2 Clofazimine
31 Phase IIa Prospective Study to Evaluate the Safety and Measure Efficacy of Anti-chlamydophila Antibiotic Combination (ACAC) Therapy Comprising 100mg Doxycycline, 500mg Azithromycin and 300mg Rifabutin in the Treatment of Patients With Coronary Heart Disease (CHD) Recruiting NCT03618108 Phase 2 Doxycycline Capsule;Azithromycin Capsule;Rifabutin Oral Capsule;Placebo oral capsule;Placebo Oral Tablet;Placebo oral capsule
32 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Mutations in GATA2 or the MonoMAC Syndrome Recruiting NCT01861106 Phase 2 Busulfan Test dose;Fludarabine (Fludara, Berlex Laboratories);Busulfan (Busulfex);Cyclophosphamide(CTX, Cytoxan);Mycophenolatemofetil (MMF);Tacrolimus
33 A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterials in Previously Treated or Mod-to-Sev Pulmonary Mycobacterium Avium Complex Infection Terminated NCT00043355 Phase 2 interferon gamma-1b
34 Improving Tolerance of Treatment of Pulmonary Mycobacterium Avium Complex Infections Withdrawn NCT01719042 Phase 2 Zofran (8mg)
35 Inhaled Amikacin for Treatment of Intractable Nontuberculous Mycobacterial Lung Disease Withdrawn NCT01528930 Phase 2 Amikacin
36 Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra Unknown status NCT01259219 Phase 1 Mycobutin
37 A Phase I/II Dose-Ranging, Pharmacokinetic, Drug Interaction, Safety and Preliminary Efficacy Study of Oral Clarithromycin Granules for Suspension, in Combination With Zidovudine or Dideoxyinosine, in the Treatment of Disseminated Mycobacterium Avium Complex Infections in Pediatric Patients With AIDS Completed NCT00000971 Phase 1 Clarithromycin;Zidovudine;Didanosine
38 Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV Completed NCT00002104 Phase 1 Thalidomide
39 A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc Completed NCT01894776 Phase 1 Rifabutin;Maraviroc
40 A Phase I Clinical Trial to Determine the Safety and Immunogenicity of the Candidate Mycobacterium Avium Subspecies Paratuberculosis (MAP) Vaccines ChAdOx2 HAV and MVA HAV in Healthy Adult Volunteers Completed NCT03027193 Phase 1
41 A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex and Other Pulmonary Nontuberculous Mycobacterial Infections Completed NCT00111397 Phase 1 Interferon Gamma, GM-CSF
42 Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection Completed NCT00001763 Phase 1 Interleukin-12
43 A Phase I, Double-Blind, Randomized, Placebo-Controlled Trial of Recombinant Human Interleukin-12 (rhIL-12) in HIV-Infected Subjects With Less Than 50 CD4+ T Cells and Subjects With 300-500 CD4+ T Cells Completed NCT00000857 Phase 1 Interleukin-12
44 Steady-State Pharmacokinetic Interaction Study of Indinavir and Rifabutin Completed NCT00000877 Phase 1 Indinavir sulfate;Rifabutin
45 A Phase 1, Open-Label, 2-Arm, Fixed-Sequence Study to Evaluate the Potential Effects of Multiple Doses of Rifampin (CYP3A4 Inducer) and Clarithromycin (CYP3A4 Inhibitor) on the Single Dose Pharmacokinetics of Deflazacort in Healthy Subjects Completed NCT02286635 Phase 1 Deflazacort and rifampin;Deflazacort and Clarithromycin
46 A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study) Not yet recruiting NCT04294043 Phase 1 Gallium nitrate
47 The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease Unknown status NCT02005094
48 Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation Unknown status NCT01676142
49 The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and Bronchiolitis Unknown status NCT01354912
50 An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy Completed NCT00002089 Azithromycin

Search NIH Clinical Center for Mycobacterium Avium Complex Infections

Genetic Tests for Mycobacterium Avium Complex Infections

Anatomical Context for Mycobacterium Avium Complex Infections

MalaCards organs/tissues related to Mycobacterium Avium Complex Infections:

40
Lung, Lymph Node, T Cells, Testes, Bone, Bone Marrow, Colon

Publications for Mycobacterium Avium Complex Infections

Articles related to Mycobacterium Avium Complex Infections:

(show top 50) (show all 244)
# Title Authors PMID Year
1
Mycobacterium avium Complex Disease. 52
28429679 2017
2
Horseshoe abscess of the hand with rice bodies secondary to mycobacterium avium intracellulare infection. 61
32120309 2020
3
Massive Splenomegaly from Disseminated Mycobacterium avium-intracellulare Infection. 61
32160665 2020
4
Evaluation of direct 16S rRNA PCR from clinical samples for bacterial detection in normally sterile body sites. 61
32087069 2019
5
Mycobacterium avium-intracellulare septic arthritis of the sternoclavicular joint in an immunocompetent host; a three-year follow-up. 61
31439192 2019
6
Esophageal Mycobacterium avium-intracellulare infection in a bone marrow transplant patient: Case report and literature review. 61
30371970 2019
7
Concurrent Persistent Cryptococcosis and Mycobacterium avium Complex Infections in a Patient With Human Immunodeficiency Virus. 61
31258430 2019
8
Mycobacterium avium intracellulare infection complicated by allergic bronchopulmonary aspergillosis in a non-asthmatic patient. 61
29804082 2018
9
Splenic Involvement in Disseminated Mycobacterium avium-intracellulare Infection: Magnetic Resonance Imaging Findings. 61
28708727 2018
10
A case of hypercalcaemia in an immunocompetent patient with Mycobacterium avium intracellulare. 61
28748100 2017
11
A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment. 61
28538280 2017
12
Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease. 61
27872066 2017
13
Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy. 61
28337084 2017
14
Usefulness of Chinese Herbal Medicines as Host-Directed Therapeutics against Mycobacterial Infections: A Review. 61
29121801 2017
15
Host-Directed Therapeutics against Mycobacterial Infections. 61
27908271 2017
16
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. 61
25619630 2015
17
Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy. 61
24618936 2014
18
Cervical lymphadenopathy in young children: case report of nontuberculous mycobacterial infection. 61
25303510 2014
19
Gamma interferon receptor defect presenting as recurrent tuberculosis. 61
23681833 2014
20
Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet? 61
23658257 2013
21
Management of uterine bleeding during hematopoietic stem cell transplantation. 61
23344397 2013
22
Mai infection simulating metastatic breast cancer. 61
23144339 2012
23
Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 61
23071188 2012
24
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. 61
21980068 2012
25
Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. 61
22481952 2012
26
[Lady Windermere syndrome]. 61
22420095 2012
27
Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung. 61
21399527 2011
28
The Effect of Mycobacterium avium Complex Infections on Routine Mycobacterium bovis Diagnostic Tests. 61
21772961 2011
29
Structural-functional dissociation in presumed ethambutol optic neuropathy. 61
20592624 2010
30
Disseminated Mycobacterium avium intracellulare infection in an "immunocompetent" host. 61
20531046 2010
31
The Lady Windermere syndrome. 61
19455268 2009
32
Fatal dual infection with Salmonella and Mycobacterium avium complex infection in a patient with advanced acquired immunodeficiency syndrome: a case report. 61
20181177 2009
33
Mycobacterium avium-intracellulare infection presenting as a testicular mass in an immunocompromised patient: a case report. 61
19918356 2009
34
Disseminated Mycobacterium avium-intracellulare infection presenting as multiple ring-enhancing lesions on brain MRI. 61
19411433 2009
35
[Molecular diagnosis of human histoplasmosis in whole blood samples]. 61
19391520 2009
36
Pedicled latissimus dorsi muscle flap: routine use in high-risk thoracic surgery. 61
19693302 2009
37
Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. 61
19145124 2008
38
Immune-reconstitution syndrome related to atypical mycobacterial infection in AIDS. 61
18728545 2008
39
Mediastinal Mycobacterium avium-intracellulare infection diagnosed by transesophageal endoscopic ultrasound-guided fine-needle biopsy. 61
18691205 2008
40
Histopathological classification of systemic Mycobacterium avium complex infections in slaughtered domestic pigs. 61
17629560 2008
41
Rare presentation of Mycobacterium avium-intracellulare infection. 61
17113692 2007
42
Disseminated Mycobacterium avium-intracellulare infection in a person with AIDS with cutaneous and CNS lesions. 61
18170919 2007
43
A patient with acquired immunodeficiency syndrome (AIDS) and a cutaneous Mycobacterium avium intracellulare infection mimicking histoid leprosy. 61
17667188 2007
44
Mycobacterium avium-intracellulare cellulitis occurring with septic arthritis after joint injection: a case report. 61
17324257 2007
45
HIV-associated opportunistic infections. Bacterial infections. 61
17086998 2006
46
Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection. 61
16078343 2005
47
["White bowel". A sonographic sign of intestinal lymph edema?]. 61
15852176 2005
48
Cutaneous Mycobacterium avium intracellulare infection in an HIV+ patient mimicking histoid leprosy. 61
15677976 2005
49
Bacterial pericarditis: diagnosis and management. 61
15725041 2005
50
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. 61
16089023 2005

Variations for Mycobacterium Avium Complex Infections

Expression for Mycobacterium Avium Complex Infections

Search GEO for disease gene expression data for Mycobacterium Avium Complex Infections.

Pathways for Mycobacterium Avium Complex Infections

GO Terms for Mycobacterium Avium Complex Infections

Sources for Mycobacterium Avium Complex Infections

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....